The nation of Zimbabwe has declined a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' insistence on confidential data.
The decision became public following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official representative later clarified that the United States was demanding access to health data for research and profit while refused to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further negotiations to reach a agreement suitable to all parties so the nation's critical HIV programme can be sustained.
Wider Context
This rejection comes after a comparable case in Kenya, where a high court suspended a similar deal with the US after concerns were filed about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
Based on reports, 16 nations in Africa have so far signed these new health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our people should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems already established via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued discussions with our American counterparts on how subsequent co-operation might be designed in a manner that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but suggested that talks should continue given that much of the nation's HIV programmes were funded by external financing.
"In cases where technical issues arise, such as those involving information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it commented.
The halted deal emphasises the complex tensions between receiving vital international aid and protecting a country's data in an ever more data-driven world.